Lars-Olof Hansson
Chairman at EUROPEAN INSTITUTE OF SCIENCE AB
Net worth: 2 M $ as of 2024-04-29
Network origin in Lars-Olof Hansson first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Karolinska Institutet
126
| College/University | Other Consumer Services | 126 |
| Public Company | Electronic Equipment/Instruments | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Lars-Olof Hansson via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Cellectricon AB
 Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| LIFEASSAYS AB (PUBL) | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
| ACTIVE BIOTECH AB | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| MEDA AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
Din Bostad Sverige AB
 Din Bostad Sverige AB Real Estate DevelopmentFinance Din Bostad Sverige AB operates a residential property business. The company is headquartered in Huddinge, Sweden. | Real Estate Development | Director/Board Member Chief Tech/Sci/R&D Officer | |
Royal Swedish Academy of Sciences
 Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Sciences provides research and development services on sciences. The non-profit company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| OREXO AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Uppsala | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Accuro Immunology AB
 Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Stockholm | College/University | Doctorate Degree Director/Board Member Graduate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Founder Founder Corporate Officer/Principal | |
| University of Lund | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Graduate Degree | |
Fastilium Property Group AB
 Fastilium Property Group AB Real Estate DevelopmentFinance Fastilium Property Group AB engages in the development and management of residential and commercial properties. The company was founded on June 7, 2006, and is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member Chief Executive Officer | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Gothenburg | College/University | Doctorate Degree Corporate Officer/Principal | |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | President President | |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder | |
Rhenman & Partners Asset Management AB
 Rhenman & Partners Asset Management AB Investment ManagersFinance Rhenman & Partners Asset Management AB (Rhenman & Partners) is an independent Swedish alternative investment management firm which was founded in 2008 by a group of senior asset management industry executives including Henrik Rhenman and Göran Nordström. Headquartered in Stockholm, the firm is exclusively focused on the healthcare sector and manages the Rhenman Healthcare Equity L/S Fund, supported by a Scientific Advisory Board with a network of scientists and experts at renowned scientific institutions, including the Karolinska Institute and the University of Uppsala. | Investment Managers | Chairman Analyst-Equity | |
| BIOARCTIC AB | Pharmaceuticals: Major | Founder Director/Board Member | |
Karolinska Institutet Innovations AB
 Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Chairman Director/Board Member Director/Board Member | |
| Vetenskapsrådet | Director/Board Member Corporate Officer/Principal | ||
| Center for Molecular Medicine (Sweden) | Director/Board Member Corporate Officer/Principal | ||
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member Founder | |
| NEOS AB | Medical Specialties | Director/Board Member Founder Founder | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Karolinska University Hospital
 Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Hospital/Nursing Management | Corporate Officer/Principal Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| INTERVACC AB | Biotechnology | Chief Executive Officer Director/Board Member | |
| KANCERA AB | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Chairman Director/Board Member Director/Board Member Chief Operating Officer Director/Board Member | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Founder | |
| INHALATION SCIENCES SWEDEN AB | Medical Specialties | Director/Board Member Founder | |
| CALMARK SWEDEN AB | Medical Specialties | Director/Board Member Director/Board Member | |
Biotech-IgG Equity AB
 Biotech-IgG Equity AB Medical SpecialtiesHealth Technology Biotech-IgG Equity AB engages in the distribution of medical diagnostic and life science products. It offers kits and reagents; assays and reagents for real-time polymerase chain reaction (PCR); PCR instrumentation; clinical microbiology; nuclear instrumentation; radiochemical; automatic liquid handling; and antibodies and proteins. The company was founded in 1996 and is headquartered in Karlstad, Sweden. | Medical Specialties | Chief Executive Officer Chief Executive Officer | |
| VALNEVA | Biotechnology | Director/Board Member Director/Board Member | |
| PEPTONIC MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Founder | |
Disruptive Materials AB
 Disruptive Materials AB Chemicals: Major DiversifiedProcess Industries Disruptive Materials AB manufactures mesoporous magnesium carbonate. It focuses on commercializing the material Upsalite that can be used in applications such as desiccant for humidity control, pharmaceutics, adsorbent for waste handling, thermal and acoustic insulation, cosmetics, adsorbent in ink jet paper,and bio material applications. The company was founded by Johan A. V. Gómez de la Torre, Maria Strømme, Lars-Erik Mattias Karls, and Sara Kristina Frykstrand Ångström in December 2011 and is headquartered in Uppsala, Sweden. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
| INITIATOR PHARMA A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder | |
Spatial Transcriptomics AB
 Spatial Transcriptomics AB Miscellaneous Commercial ServicesCommercial Services Spatial Transcriptomics AB develops technology for RNA sequencing. Its system bridges microscopy and RNA sequencing to generate complete transcriptome data from a single intact tissue sample, and utilizes standard instrumentation for sequencing. The firm's products include ST Tissue Optimization Slide and ST Library Preparation Slide. The company was founded by Jonas Christopher Frisén, Joakim Lundeberg, and Patrik Ståhl and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| BACTIGUARD HOLDING AB | Medical Specialties | Director/Board Member Director/Board Member |
Statistics
International
| Sweden | 45 |
| United Kingdom | 2 |
| Austria | 2 |
| Switzerland | 2 |
| France | 2 |
Sectoral
| Health Technology | 32 |
| Commercial Services | 6 |
| Finance | 6 |
| Consumer Services | 5 |
| Health Services | 3 |
Operational
| Director/Board Member | 347 |
| Corporate Officer/Principal | 216 |
| Chairman | 83 |
| Founder | 67 |
| Independent Dir/Board Member | 63 |
Most connected contacts
- Stock Market
- Insiders
- Lars-Olof Hansson
- Company connections
